enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Prescription drug prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Prescription_drug_prices...

    Within the year of 2014, the cost of prescriptions had increased by at least 11.4% and 58% within the last eight years. The average cost for a month supply of brand-name drugs can run up to a couple of hundred US dollars, whereas in Canada and Great Britain the same medication could cost up to $40 US dollars.

  3. Pembrolizumab - Wikipedia

    en.wikipedia.org/wiki/Pembrolizumab

    Pembrolizumab, sold under the brand name Keytruda, is a humanized antibody, more specifically a PD-1 inhibitor, used in cancer immunotherapy that treats melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, stomach cancer, cervical cancer, and certain types of breast cancer.

  4. Health care prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Health_care_prices_in_the...

    The U.S. consumes 3 times as many mammograms, 2.5x the number of MRI scans, and 31% more C-sections per-capita than peer countries. This is a blend of higher per-capita income and higher use of specialists, among other factors. [4] The U.S. government intervenes less actively to force down prices in the United States than in other countries ...

  5. Merck posts better-than-expected results on Keytruda ... - AOL

    www.aol.com/news/merck-posts-better-expected...

    Keytruda sales rose 21% to $6.6 billion as the company was able to increase use of the drug in earlier stage cancers, topping analyst forecasts of $6.5 billion. ... The New Jersey-based drugmaker ...

  6. Merck Banks on Keytruda, Pipeline & Deals Amid Generic Woes - AOL

    www.aol.com/news/merck-banks-keytruda-pipeline...

    Keytruda, approved for several types of cancer, alone accounts for more than 25% of Merck's (MRK) pharmaceutical sales Animal health and vaccine products remain core growth drivers.

  7. Merck's Keytruda Picks Up Pace in Thriving Anti-PD-L1 Market

    www.aol.com/news/mercks-keytruda-picks-pace...

    Merck's (MRK) Keytruda is rapidly gaining strength as a key contributor to the company's top line. The Keytruda development program is also progressing well. Merck's Keytruda Picks Up Pace in ...

  8. Drugs in pregnancy - Wikipedia

    en.wikipedia.org/wiki/Drugs_in_pregnancy

    Opioid use during pregnancy may cause adverse outcomes for the women and unborn child. [11] Women who use opioids during pregnancy in a non-medical fashion are at a higher risk for premature birth, lower birth weight, still birth, specific birth defects, and withdrawal (neonatal abstinence syndrome). [11]

  9. Merck's Experimental Favezelimab/Keytruda Combo Fails ... - AOL

    www.aol.com/mercks-experimental-favezelimab...

    Keytruda has not been approved for the treatment of MSS mCRC. Last month, Merck stopped two Keytruda Phase 3 trials, KEYNOTE-867 and KEYNOTE-630, after underwhelming data .